LIBTAYO (cemiplimab-rwlc)
ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · BASAL CELL CARCINOMA OF SKIN ·+3
Regeneron Pharmaceuticals, Inc.
Sponsored